JP2009542786A5 - - Google Patents

Download PDF

Info

Publication number
JP2009542786A5
JP2009542786A5 JP2009518955A JP2009518955A JP2009542786A5 JP 2009542786 A5 JP2009542786 A5 JP 2009542786A5 JP 2009518955 A JP2009518955 A JP 2009518955A JP 2009518955 A JP2009518955 A JP 2009518955A JP 2009542786 A5 JP2009542786 A5 JP 2009542786A5
Authority
JP
Japan
Prior art keywords
compound
pur
precursor
dac
arc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009518955A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009542786A (ja
JP5350237B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2007/002570 external-priority patent/WO2008007074A2/en
Publication of JP2009542786A publication Critical patent/JP2009542786A/ja
Publication of JP2009542786A5 publication Critical patent/JP2009542786A5/ja
Application granted granted Critical
Publication of JP5350237B2 publication Critical patent/JP5350237B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009518955A 2006-07-11 2007-07-10 ジアミノフェノチアジニウム化合物の合成および／または精製の方法 Active JP5350237B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81962706P 2006-07-11 2006-07-11
US60/819,627 2006-07-11
PCT/GB2007/002570 WO2008007074A2 (en) 2006-07-11 2007-07-10 Methods of synthesis and/or purification of diaminophenothiazinium compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013171087A Division JP6243659B2 (ja) 2006-07-11 2013-08-21 ジアミノフェノチアジニウム化合物の合成および／または精製の方法

Publications (3)

Publication Number Publication Date
JP2009542786A JP2009542786A (ja) 2009-12-03
JP2009542786A5 true JP2009542786A5 (cg-RX-API-DMAC10.html) 2010-08-26
JP5350237B2 JP5350237B2 (ja) 2013-11-27

Family

ID=38669650

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009518955A Active JP5350237B2 (ja) 2006-07-11 2007-07-10 ジアミノフェノチアジニウム化合物の合成および／または精製の方法
JP2013171087A Active JP6243659B2 (ja) 2006-07-11 2013-08-21 ジアミノフェノチアジニウム化合物の合成および／または精製の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013171087A Active JP6243659B2 (ja) 2006-07-11 2013-08-21 ジアミノフェノチアジニウム化合物の合成および／または精製の方法

Country Status (16)

Country Link
US (10) US7956183B2 (cg-RX-API-DMAC10.html)
EP (5) EP4063354A1 (cg-RX-API-DMAC10.html)
JP (2) JP5350237B2 (cg-RX-API-DMAC10.html)
CN (2) CN101511803B (cg-RX-API-DMAC10.html)
AU (1) AU2007274057B2 (cg-RX-API-DMAC10.html)
CA (1) CA2657352C (cg-RX-API-DMAC10.html)
CY (1) CY1118184T1 (cg-RX-API-DMAC10.html)
DK (4) DK2057136T3 (cg-RX-API-DMAC10.html)
ES (4) ES2421930T3 (cg-RX-API-DMAC10.html)
HU (1) HUE030621T2 (cg-RX-API-DMAC10.html)
LT (1) LT2457905T (cg-RX-API-DMAC10.html)
MY (2) MY162313A (cg-RX-API-DMAC10.html)
PL (4) PL2457904T3 (cg-RX-API-DMAC10.html)
PT (4) PT2457905T (cg-RX-API-DMAC10.html)
SI (4) SI2057136T1 (cg-RX-API-DMAC10.html)
WO (1) WO2008007074A2 (cg-RX-API-DMAC10.html)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006032879A2 (en) 2004-09-23 2006-03-30 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
CN104119294B (zh) 2006-03-29 2018-10-30 维斯塔实验室有限公司 3,7-二氨基-10h-吩噻嗪化合物的制备方法
MY162313A (en) 2006-07-11 2017-05-31 Wista Lab Ltd Methods of synthesis and/or purification of diaminophenothiazinium compounds
FR2903696B1 (fr) * 2006-07-12 2011-02-11 Provence Technologies Procede de purification de composes diaminophenothiazium
AU2008265045B2 (en) * 2007-06-19 2014-02-27 Taurx Therapeutics Management Ltd. Phenothiazine compounds for treating Mild Cognitive Impairment
PT2954932T (pt) 2007-10-03 2018-12-12 Wista Lab Ltd Utilização terapêutica de diaminofenotiazinas
MX2011005979A (es) * 2008-12-09 2011-06-27 Interquim Sa Procedimiento de obtencion de (6s)-(-)-5,6,7,8-tetrahidro-6-[propi l-(2-tienil)etil]amino-1-naftol(rotigotina).
US8785434B2 (en) 2010-04-30 2014-07-22 Prosetta Antiviral Inc. Antiviral compounds
US8828986B2 (en) 2011-04-20 2014-09-09 Prosetta Antiviral Inc. Antiviral compounds
DE102010062810B4 (de) * 2010-09-07 2014-03-13 Immungenetics Ag 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen ausgewählt aus beta-Amyloidopathien und alpha-Synucleinopathien
KR101888713B1 (ko) 2011-02-11 2018-08-14 위스타 레보레이토리스 리미티드 페노티아진 디아미늄 염 및 이의 용도
RU2535073C1 (ru) * 2013-07-18 2014-12-10 Федеральное государственное бюджетное учреждение науки "Научно-исследовательский институт общей реаниматологии имени В.А. Неговского" Российской академии медицинских наук Способ лечения метгемоглобинемии
DK3033331T3 (da) * 2013-08-15 2018-04-30 Eupharma Pty Ltd Fremgangsmåde til oprensning af diaminophenothiazinium forbindelser
GB201317702D0 (en) * 2013-10-07 2013-11-20 Wista Lab Ltd Methods of chemical synthesis of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
FR3015481B1 (fr) * 2013-12-20 2016-08-12 Etat Francais Represente Par Le Delegue General Pour L'armement Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite
CN103864717B (zh) * 2014-04-04 2015-11-11 山东理工大学 一种针状亚甲基白晶体的制备方法
CA2976937C (en) 2015-02-17 2023-04-04 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
CA2976776C (en) 2015-02-17 2023-06-20 Arizona Board Of Regents On Behalf Of Arizona State University Phenothiazine analogues as mitochondrial therapeutic agents
GB201512678D0 (en) 2015-07-20 2015-08-26 Wista Lab Ltd Methods of chemical synthesis
CN105399703B (zh) * 2015-12-15 2018-02-13 江苏恒润制药有限公司 一种亚甲基蓝的制备方法
CN105541756B (zh) * 2015-12-17 2018-02-09 陕西方舟制药有限公司 一种制备1‑(3，7‑双二甲氨基‑吩噻嗪‑10‑基)乙酮的方法
ITUA20163526A1 (it) 2016-05-17 2017-11-17 Icrom Spa Procedimento per la preparazione di composti diamminofenotiazinici ad elevato grado di purezza
PL3487505T3 (pl) 2016-07-25 2023-10-09 Wista Laboratories Ltd. Podawanie i dawkowanie diaminofenotiazyn
WO2018039487A1 (en) * 2016-08-25 2018-03-01 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US12570622B2 (en) 2016-08-25 2026-03-10 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US11390605B2 (en) 2016-08-25 2022-07-19 Arizona Board Of Regents On Behalf Of Arizona State University Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
GB201614834D0 (en) 2016-09-01 2016-10-19 Wista Lab Ltd Treatment of dementia
GB201621817D0 (en) 2016-12-21 2017-02-01 Wista Lab Ltd Methods of chemical synthesis
WO2018126107A1 (en) 2016-12-29 2018-07-05 Board Of Regents, The University Of Texas System Methylene blue solution for the treatment of oral lesions
US10584201B2 (en) * 2017-01-10 2020-03-10 The Texas A&M University System Methanesulfonic acid mediated solvent free synthesis of conjugated porous polymer networks
FR3063495B1 (fr) * 2017-03-02 2019-04-05 Provepharm Life Solutions Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium
EP3375777A1 (en) * 2017-03-15 2018-09-19 MIKROCHEM spol. s.r.o. Method for preparation of 3,7-bis-(dimethylamino)-phenothiazin-5-ium chloride or bromide
BR112021000802A2 (pt) 2018-07-26 2021-04-13 Wista Laboratories Ltd. Dosagem otimizada de diaminofenotiazinas em populações
US11350853B2 (en) 2018-10-02 2022-06-07 Under Armour, Inc. Gait coaching in fitness tracking systems
CN109337681B (zh) * 2018-11-22 2020-05-08 南京工业大学 一种硫氮共掺杂的碳量子点的制备方法和应用
TR201818670A2 (tr) 2018-12-05 2020-06-22 Eti Gida Sanayi Ve Ticaret Anonim Sirketi Sızıntı yapmayan gıda dolgu maddesi depozitör sistemi.
US12215234B2 (en) * 2019-09-21 2025-02-04 RK Pharma Solutions LLC Process for the purification of methylene blue
US12441694B2 (en) * 2020-02-28 2025-10-14 Dishman Carbogen Amcis Ltd. Process for the preparation of methylene blue
US12280062B2 (en) 2021-02-24 2025-04-22 Zydus Lifesciences Limited Parenteral compositions comprising methylene blue
CN114656424B (zh) * 2022-03-16 2023-06-27 深圳先进技术研究院 一种上转换长余辉化学发光成像纳米探针及其制备方法和应用
CN114806211B (zh) * 2022-03-16 2023-04-07 深圳先进技术研究院 一种疏水性亚甲蓝荧光染料及其制备方法和应用
CN114507193B (zh) * 2022-04-19 2022-06-24 英科隆生物技术（杭州）有限公司 电子媒介体天青c的提纯方法
US20250270177A1 (en) * 2022-04-19 2025-08-28 Leadway (Hk) Limited Purification method for electron mediator
CN116947783B (zh) * 2022-04-19 2026-04-17 英科隆生物技术（杭州）有限公司 一种电子媒介体的提纯方法
CA3257856A1 (en) 2022-05-31 2023-12-07 Wista Laboratories Ltd. TREATMENT OF NEURODEGENERATIVE DISORDERS USING COMPOUNDS CONTAINING METHYLTHIONINIUM (MT)
CN114989113A (zh) * 2022-06-01 2022-09-02 山东科源制药股份有限公司 一种药用亚甲基蓝的精制方法
WO2024063700A1 (en) 2022-09-21 2024-03-28 Yin Sze Loh Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases
EP4342451A1 (en) 2022-09-22 2024-03-27 Galenicum Health SLU Pharmaceutical compositions and manufacturing methods thereof
US20240115579A1 (en) 2022-09-22 2024-04-11 Galenicum Health S.L.U. Pharmaceutical compositions and manufacturing methods thereof
CN117447421A (zh) * 2023-10-30 2024-01-26 上海沃凯生物技术有限公司 一种3,7-双-（二甲胺基）-吩噻嗪的合成方法
IT202400006715A1 (it) * 2024-03-26 2025-09-26 Icrom S R L Blu di metilene a ridotto contenuto di impurità n-nitroso-azzurro b e processo per ottenerlo
GB202500018D0 (en) 2025-01-02 2025-02-19 Wista Lab Ltd Long term dosing of neurodegenerative disorders utilising methylthioninium (mt) containing compounds
CN119823064B (zh) * 2025-01-03 2025-12-30 仁合益康集团有限公司 一种亚甲蓝的制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1886C (de) 1877-12-15 1877-12-15 Basf Ag Verfahren zur darstellung blauer farbstoffe aus dimethylanilin und anderen tertiaeren aromatischen monaminen
DE103147C (de) 1898-06-07 1899-04-05 Cohn Georg Verfahren zur darstellung von acetylleukomethylenblau und -äthylenblau.
DE113721C (de) * 1899-06-01 1900-09-28 Verfahren zur Darstellung von Acidylderivaten der Leukothioninfarbstoffe
US3395018A (en) 1964-04-29 1968-07-30 Du Pont Light-sensitive color-forming composition
US3641016A (en) * 1968-02-16 1972-02-08 Egyt Gyogyszervegyeszeti Gyar Thionine derivatives
DE2515966C3 (de) 1975-04-11 1979-11-22 Boehringer Mannheim Gmbh, 6800 Mannheim Vorgefärbte Objektträger für die Blutunte rsuchung
US4003892A (en) 1975-04-17 1977-01-18 Serva-Entwicklungslabor V. Grothe & Co. Method of separating thionine and its N-methyl derivatives from each other
US4212971A (en) 1979-03-08 1980-07-15 American Cyanamid Company Process for preparing methylene blue
JPS6385644A (ja) * 1986-09-30 1988-04-16 Ricoh Co Ltd 電子写真現像剤用トナ−
US5344928A (en) 1991-04-26 1994-09-06 Takeda Chemical Industries, Ltd. Phenothiazine derivatives, their production and use
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
GB9506197D0 (en) 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
WO1998031219A1 (en) 1997-01-21 1998-07-23 The American National Red Cross Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light
JP2000344685A (ja) 1999-03-26 2000-12-12 Bf Kenkyusho:Kk アズールａ類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物
IT1307270B1 (it) 1999-10-12 2001-10-30 Dideco Spa Procedimento e dispositivo per la determinazione della concentrazionedi eparina in un campione di fluido.
EP1263465B9 (en) * 2000-02-26 2012-12-05 Advanced Photodynamic Technologies, Inc. Photodynamic cellular organism eradication using a photosensitive material and surfactant
FR2810318B1 (fr) 2000-06-15 2005-09-23 Laurent Galey Derives de diamano-phenothiazine
GB0101049D0 (en) 2001-01-15 2001-02-28 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB2373787A (en) 2001-03-08 2002-10-02 Univ Central Lancashire Phenothiazinium derivatives and their use to reduce pathogenic contaminants
GB0106953D0 (en) 2001-03-20 2001-05-09 Univ Aberdeen Neufofibrillary labels
GB0113121D0 (en) 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
US7176308B2 (en) * 2002-06-17 2007-02-13 Verification Technologies, Inc. Processes for preparing novel methylene blue derivative
GB0322756D0 (en) 2003-09-29 2003-10-29 Univ Aberdeen Methods of chemical synthesis
BRPI0416928A (pt) 2003-11-28 2007-01-16 Photopharmica Ltd desenvolvimento de derivados biologicamente ativos de azul de metileno
WO2006032879A2 (en) 2004-09-23 2006-03-30 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
JP5186212B2 (ja) 2004-09-23 2013-04-17 ウィスタ ラボラトリーズ リミテッド メチルチオニニウム塩化物（ｍｔｃ）などのジアミノフェノチアジニウム化合物を化学合成および精製する方法
CN104119294B (zh) 2006-03-29 2018-10-30 维斯塔实验室有限公司 3,7-二氨基-10h-吩噻嗪化合物的制备方法
MY162313A (en) * 2006-07-11 2017-05-31 Wista Lab Ltd Methods of synthesis and/or purification of diaminophenothiazinium compounds
FR2903696B1 (fr) 2006-07-12 2011-02-11 Provence Technologies Procede de purification de composes diaminophenothiazium
KR101888713B1 (ko) 2011-02-11 2018-08-14 위스타 레보레이토리스 리미티드 페노티아진 디아미늄 염 및 이의 용도
PL3487505T3 (pl) 2016-07-25 2023-10-09 Wista Laboratories Ltd. Podawanie i dawkowanie diaminofenotiazyn
GB201614834D0 (en) 2016-09-01 2016-10-19 Wista Lab Ltd Treatment of dementia
GB201621817D0 (en) 2016-12-21 2017-02-01 Wista Lab Ltd Methods of chemical synthesis
BR112021000802A2 (pt) 2018-07-26 2021-04-13 Wista Laboratories Ltd. Dosagem otimizada de diaminofenotiazinas em populações
GB201909454D0 (en) 2019-07-01 2019-08-14 Wista Lab Ltd Enhancers
GB201909506D0 (en) 2019-07-02 2019-08-14 Wista Lab Ltd Synaptopathies

Similar Documents

Publication Publication Date Title
CN1235902C (zh) 头孢地尼结晶酸盐及用其制备头孢地尼的方法
EP2301911A1 (en) Process for producing oseltamivir phosphate and intermediate compound
WO2022141229A1 (zh) 三氯蔗糖的制备方法、粗产品溶液及三氯蔗糖
WO2005021563A2 (en) Method and materials for bisulfite conversion of cytosine to uracil
CN101875665B (zh) 一种厄他培南中间体、含其的组合物及其制备方法
KR20010050873A (ko) 사이클로헥산디메탄올 등의 알코올류의 제조방법
Sabitha et al. Lithium chloride catalysed acetylation of alcohols, thiols, phenols and amines
CN101704827B (zh) 一种头孢硫脒化合物的合成方法
CN106632399A (zh) 一种头孢沙定母核的合成方法
CN110294724A (zh) 一种催化氧化乙酰呋喃制备2-呋喃基乙醛酸的方法
CN1098267C (zh) 3－烯基头孢烯化合物的制备方法
CN1922145A (zh) 制备瑞巴派特的改进的方法
CN114560894B (zh) 一种抗新冠药物Molnupiravir的制备方法
JP2012532186A5 (cg-RX-API-DMAC10.html)
JP6476591B2 (ja) （２Ｒ）−２−フルオロ−２−Ｃ−メチル−Ｄ−リボノ−γ−ラクトン類の製造方法
CN114874115A (zh) 一种不对称的硫代磺酸化合物的合成方法
CN114230449A (zh) 一种邻氯苯甲酸-14c及制备方法
CN101918349B (zh) 制备双醋瑞因的方法
CN100345864C (zh) 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
KR100235749B1 (ko) 말론산디알킬에스터의 개선된 분리방법
CN112321582B (zh) 一种泰比培南侧链的合成及中间体的精制方法
CN118754896A (zh) 一种头孢妥仑匹酯的制备方法
CN1314691C (zh) 法罗培南钠的制备方法
CN110386614A (zh) 一种同时获得大、中、小孔径拟薄水铝石的制备方法
CN101735285B (zh) 一种1,2,5-O-三酰基-3-脱氧-α-D-呋喃木糖的制备方法